All News #Library
Biotech
GigaGen Doses 1st Patient in Ph 1 of GIGA-2339 for Hepatitis B
19 Nov 2024 //
GLOBENEWSWIRE
GigaGen garners up to $135M BARDA bucks to beat botulism
03 Oct 2024 //
FIERCE BIOTECH
GigaGen Doses First GIGA-564 Anti-CTLA-4 Solid Tumor Patient
20 May 2024 //
GLOBENEWSWIRE
GigaGen Receives FDA Clearance of IND to Begin Phase 1 Trial of GIGA-564
12 Dec 2023 //
GLOBENEWSWIRE
GigaGen Granted Expansion of Contract to Develop Synthetic Human Antibody
19 Oct 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support